How big is the Asia Pacific Peripheral Embolization Coils Market?

The Asia Pacific Peripheral Embolization Coils Market is valued at US$ 138.45 Million in 2023, it is projected to reach US$ 204.52 Million by 2031.

What is the CAGR for Asia Pacific Peripheral Embolization Coils Market by (2023 - 2031)?

As per our report Asia Pacific Peripheral Embolization Coils Market, the market size is valued at US$ 138.45 Million in 2023, projecting it to reach US$ 204.52 Million by 2031. This translates to a CAGR of approximately 5.0% during the forecast period.

What segments are covered in this report?

The Asia Pacific Peripheral Embolization Coils Market report typically cover these key segments- 类型（可拆卸弹簧圈、可推入弹簧圈）材质（铂金、铂金与水凝胶、铂钨合金）应用（出血和创伤、畸形、肿瘤、内脏动脉瘤、II 型内漏、静脉曲张）

What is the historic period, base year, and forecast period taken for Asia Pacific Peripheral Embolization Coils Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Peripheral Embolization Coils Market report: 2025-2031 2023 2021-2023

Who are the major players in Asia Pacific Peripheral Embolization Coils Market?

The Asia Pacific Peripheral Embolization Coils Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include: Medtronic Plc ; Penumbra, Inc. ; Balt ; Boston Scientific Corp ; Cook Medical Holdings LLC ; Wallaby Medical ; Spartan Micro Inc. ; ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. ; Terumo Corp ; NeuroSafe Medical Co. Ltd

Who should buy this report?

The Asia Pacific Peripheral Embolization Coils Market report is valuable for diverse stakeholders, including: Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns. Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies. Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry. Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies. Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market. Essentially, anyone involved in or considering involvement in the Asia Pacific Peripheral Embolization Coils Market value chain can benefit from the information contained in a comprehensive market report.

亚太外周栓塞线圈市场（主要地区、市场参与者、规模和份额）- 预测至 2031 年

2023 年亚太外周栓塞线圈市场价值为 1.3845 亿美元，预计到 2031 年将达到 2.0452 亿美元；预计 2023 年至 2031 年的复合年增长率为 5.0%。

栓塞线圈应用范围的扩大促进了亚太外周栓塞线圈市场的发展

在外周栓塞线圈市场运营的公司不断专注于新产品的发布和市场批准，这有助于他们提高销售额。以下提到了外周栓塞线圈市场中一些值得注意的发展。2024 年 1 月，国家药品监督管理局批准了由 Zylox-Tonbridge 医疗技术有限公司生产的 ZYLOX Phoenix 外周可分离纤维线圈栓塞系统。外周血管介入是这种栓塞线圈系统最普遍的应用。该系统的其他重要临床应用包括内脏动脉瘤的栓塞治疗、腹主动脉瘤的内漏管理、咯血和动静脉瘘，其安全性和有效性得到了国际认可。2022年4月，波士顿科学公司的EMBOLD纤维可分离弹簧圈获得美国食品药品监督管理局（FDA）的510(k)批准，用于阻断或降低外周血管的血流速度。波士顿科学介入肿瘤学产品组合的最新成员旨在用于各种栓塞手术，这些手术必然是微创治疗，旨在阻断一条或多条血管以阻塞或减少血流。EMBOLD纤维可分离弹簧圈采用由三个弹簧圈组成的单一平台，使医生能够更轻松地满足各种患者的需求和解剖结构。因此，预计新产品的开发和市场批准将为预测期内外周栓塞弹簧圈市场的增长创造机会。

亚太外周栓塞线圈市场概览

亚太外周栓塞线圈市场分为中国、印度、日本、韩国、澳大利亚和亚太其他地区。该地区市场的增长归因于不断发展的医疗保健基础设施，以及欧洲各国腹主动脉瘤、急性胃肠道出血 (AGIB) 和肿瘤的发病率高。根据 2022 年 4 月发表在 BMC Public Health 上的一篇文章，中国主动脉瘤的疾病负担从 1990 年到 2020 年急剧增加，男性、老年人口和西部省份居民的死亡率更高。静脉曲张是一种常见疾病，影响着 30% 的印度人口，尤其是女性。病情会随着时间的推移而发展，导致出血、凝血和溃疡等并发症，影响患者的生活质量。静脉曲张患者极易发生深静脉血栓形成，因为静脉淤滞和损伤常常导致浅静脉炎，而浅静脉炎可通过穿孔动脉扩散并进入深静脉系统。

根据日本国家癌症中心的数据，2022 年日本记录了超过 100 万例新发肿瘤病例和 380,400 例肿瘤相关死亡病例。结直肠肿瘤、胃肿瘤、肺癌和前列腺肿瘤是日本最常见的癌症，占所有癌症病例的 45% 以上。日本前列腺癌的诊断率在过去十年中增长了 1.8 倍。大量人被诊断出患有由各种可能的风险因素引起的癌症，最明显的是人口老龄化，前列腺癌病例正在迅速激增。AGIB 是一种常见的急症，发病率和死亡率都很高。它分为上消化道出血（UGIB）和下消化道出血（LGIB），决定了患者的评估和治疗过程。据昆士兰州政府统计，在澳大利亚，每年每10万人中50-150人患上UGIB，病死率为6-8％。同一消息来源还指出，目前尚无关于澳大利亚LGIB病例的数据。根据美国国立卫生研究院发表的一篇文章，2023年，创伤在韩国主要死因中排名第三，占总死亡人数的9.2％。创伤在年轻人中更为常见，男性报告的病例是女性的两倍。韩国可预防的院内创伤病死率高于其他发达国家，为5％至10％。

亚太地区外周栓塞线圈市场收入及预测（至2031年）（百万美元）

亚太地区外周栓塞线圈市场细分

亚太地区外周栓塞线圈市场按类型、材质、应用和国家/地区分类。

根据类型，亚太地区外周栓塞线圈市场分为可分离线圈和可推动线圈。可分离线圈部分在2023年占据了更大的市场份额。

就材质而言，亚太地区外周栓塞线圈市场分为铂金、铂金和水凝胶以及铂钨合金。 2023 年，铂金细分市场占有最大份额。

根据应用，亚太地区外周栓塞线圈市场分为出血和创伤、畸形、肿瘤、内脏动脉瘤、II 型内漏和静脉曲张。2023 年，出血和创伤细分市场占有最大份额。

根据国家/地区，亚太地区外周栓塞线圈市场分为中国、日本、印度、澳大利亚、韩国和亚太其他地区。2023 年，中国占据了亚太地区外周栓塞线圈市场的主导地位。

美敦力公司；Penumbra, Inc.；Balt；波士顿科学公司；库克医疗控股有限责任公司；Wallaby Medical；Spartan Micro Inc.；ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO.; LTD.；Terumo Corp；和 NeuroSafe Medical Co. Ltd. 是亚太地区外周栓塞线圈市场领先的公司之一。

Asia Pacific Peripheral Embolization Coils Strategic Insights

Strategic insights for Asia Pacific Peripheral Embolization Coils involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-peripheral-embolization-coils-market-strategic-framework.webp

Get more information on this report

Asia Pacific Peripheral Embolization Coils Report Scope

Report Attribute	Details
Market size in 2023	US$ 138.45 Million
Market Size by 2031	US$ 204.52 Million
Global CAGR (2023 - 2031)	5.0%
Historical Data	2025-2031
Forecast period	2021-2023
Segments Covered	By 类型（可拆卸弹簧圈、可推入弹簧圈） By 材质（铂金、铂金与水凝胶、铂钨合金） By 应用（出血和创伤、畸形、肿瘤、内脏动脉瘤、II 型内漏、静脉曲张）
Regions and Countries Covered	亚太地区（印度、中国、日本、韩国、澳大利亚、亚太其他地区）亚太地区（印度、中国、日本、韩国、澳大利亚、亚太其他地区）
Market leaders and key company profiles	Medtronic Plc Penumbra, Inc. Balt Boston Scientific Corp Cook Medical Holdings LLC Wallaby Medical Spartan Micro Inc. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Terumo Corp NeuroSafe Medical Co. Ltd

Get more information on this report

Asia Pacific Peripheral Embolization Coils Regional Insights

The regional scope of Asia Pacific Peripheral Embolization Coils refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.